Free Trial

Cronos Group Q4 2023 Earnings Report

Cronos Group logo
$1.97 +0.03 (+1.55%)
As of 02/21/2025 04:00 PM Eastern

Cronos Group EPS Results

Actual EPS
-$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cronos Group Revenue Results

Actual Revenue
$23.92 million
Expected Revenue
$25.15 million
Beat/Miss
Missed by -$1.23 million
YoY Revenue Growth
N/A

Cronos Group Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Cronos Group Earnings Headlines

Cronos Group And 2 Other TSX Penny Stocks To Consider
9/9 on TSLA from June to January
Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!
Cronos Australia Ltd. Reduces Stake in Vitura Health
See More Cronos Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cronos Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cronos Group and other key companies, straight to your email.

About Cronos Group

Cronos Group (NASDAQ:CRON) operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

View Cronos Group Profile

More Earnings Resources from MarketBeat